| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | N-acetylputrescine | 655 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1196 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1480 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1571 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1573 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1620 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1732 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1970 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2003 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2175 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2376 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2398 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2427 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2585 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2643 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2814 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2816 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2873 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3085 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 3361 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3401 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3739 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3799 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3806 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3959 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4210 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4676 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 5189 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 6383 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7330 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7388 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7547 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7756 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 8602 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 8832 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 8920 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 9062 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 9290 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 10840 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 11273 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 11896 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 12201 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 13062 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 13445 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16407 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16900 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 17589 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 20865 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 23971 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 23977 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 27127 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 41711 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | N-acetylputrescine | 57018 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | N-acetylputrescine | 58270 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|